Study Finds that Biomarker May Increase Odds of Developing Alzheimer’s Disease

Higher levels of ceramides  — a certain fat in the blood — may increase a person’s risk of developing Alzheimer’s disease, according to research that appears in the July 18, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

“Our study identifies this biomarker as a potential new target for treating or preventing Alzheimer’s disease,” says author Michelle M. Mielke, PhD, an epidemiologist at the Mayo Clinic in Rochester, Minn., who was with Johns Hopkins University at the time of the research. For more information, click here to read the full release.